Photodynamic activity of tetraazachlorin derivate studied in vivo

<p>The results of investigation for photodynamic activity of new tetraazachlorin derivate – tetramethyltribenzotetraazachlorin, synthesized in Research Institute of Organic Intermediates and Dyes. The study was performed on female mice of СВА line. The tumor model was transferred solid ascetic...

Full description

Bibliographic Details
Main Authors: V. I. Ivanova-Radkevich, Е. А. Machinskaya
Format: Article
Language:Russian
Published: Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association" 2013-01-01
Series:Biomedical Photonics
Subjects:
Online Access:http://www.pdt-journal.com:80/jour/article/view/12
_version_ 1818515377076830208
author V. I. Ivanova-Radkevich
Е. А. Machinskaya
author_facet V. I. Ivanova-Radkevich
Е. А. Machinskaya
author_sort V. I. Ivanova-Radkevich
collection DOAJ
description <p>The results of investigation for photodynamic activity of new tetraazachlorin derivate – tetramethyltribenzotetraazachlorin, synthesized in Research Institute of Organic Intermediates and Dyes. The study was performed on female mice of СВА line. The tumor model was transferred solid ascetic sarcoma S-37. The samples of photosensitizer, previously solubilized in 10% aqueou s solution ofCremophor EL, injected to mice intravenously on the 7th day of tumor growth in dose of 1–2 mg/kg. Two hours later the irradiation of sensitized tumor using light emitting diode device in a maximal wavelength of 755 nm (light power density – 50 mW/cm<span><sup>2</sup></span>, maximal total light dose – 300 J/cm<span><sup>2</sup></span>) was performed. The efficacy of photodynamic therapy was assessed by growth inhibition rates in the study group comparing with control group. The study showed that photodynamic therapy with investigated sample in dose of 2 mg/kg and light dose of 300 J/cm<span><sup>2</sup></span> significantly inhibited the tumor growth (inhibition rate of 70–80% within 20 days), indicating prospectivity of subsequent investigations of tetraazachlorin as photosensitizer for photodynamic therapy of malignant tumors.</p><p> </p>
first_indexed 2024-12-11T00:28:07Z
format Article
id doaj.art-a42e1f4e6a5c44fe907d0f3c37aa6305
institution Directory Open Access Journal
issn 2413-9432
language Russian
last_indexed 2024-12-11T00:28:07Z
publishDate 2013-01-01
publisher Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"
record_format Article
series Biomedical Photonics
spelling doaj.art-a42e1f4e6a5c44fe907d0f3c37aa63052022-12-22T01:27:28ZrusNon-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"Biomedical Photonics2413-94322013-01-0122131812Photodynamic activity of tetraazachlorin derivate studied in vivoV. I. Ivanova-Radkevich0Е. А. Machinskaya1Российский Университет дружбы народов, Москва, Россия; Научно-исследовательский институт органических полупродуктов и красителей, Москва, РоссияНаучно-исследовательский институт органических полупродуктов и красителей, Москва, Россия<p>The results of investigation for photodynamic activity of new tetraazachlorin derivate – tetramethyltribenzotetraazachlorin, synthesized in Research Institute of Organic Intermediates and Dyes. The study was performed on female mice of СВА line. The tumor model was transferred solid ascetic sarcoma S-37. The samples of photosensitizer, previously solubilized in 10% aqueou s solution ofCremophor EL, injected to mice intravenously on the 7th day of tumor growth in dose of 1–2 mg/kg. Two hours later the irradiation of sensitized tumor using light emitting diode device in a maximal wavelength of 755 nm (light power density – 50 mW/cm<span><sup>2</sup></span>, maximal total light dose – 300 J/cm<span><sup>2</sup></span>) was performed. The efficacy of photodynamic therapy was assessed by growth inhibition rates in the study group comparing with control group. The study showed that photodynamic therapy with investigated sample in dose of 2 mg/kg and light dose of 300 J/cm<span><sup>2</sup></span> significantly inhibited the tumor growth (inhibition rate of 70–80% within 20 days), indicating prospectivity of subsequent investigations of tetraazachlorin as photosensitizer for photodynamic therapy of malignant tumors.</p><p> </p>http://www.pdt-journal.com:80/jour/article/view/12фотодинамическая терапияфотодинамическая активностьтетраазахлоринфотосенсибилизаторсаркома S-37
spellingShingle V. I. Ivanova-Radkevich
Е. А. Machinskaya
Photodynamic activity of tetraazachlorin derivate studied in vivo
Biomedical Photonics
фотодинамическая терапия
фотодинамическая активность
тетраазахлорин
фотосенсибилизатор
саркома S-37
title Photodynamic activity of tetraazachlorin derivate studied in vivo
title_full Photodynamic activity of tetraazachlorin derivate studied in vivo
title_fullStr Photodynamic activity of tetraazachlorin derivate studied in vivo
title_full_unstemmed Photodynamic activity of tetraazachlorin derivate studied in vivo
title_short Photodynamic activity of tetraazachlorin derivate studied in vivo
title_sort photodynamic activity of tetraazachlorin derivate studied in vivo
topic фотодинамическая терапия
фотодинамическая активность
тетраазахлорин
фотосенсибилизатор
саркома S-37
url http://www.pdt-journal.com:80/jour/article/view/12
work_keys_str_mv AT viivanovaradkevich photodynamicactivityoftetraazachlorinderivatestudiedinvivo
AT eamachinskaya photodynamicactivityoftetraazachlorinderivatestudiedinvivo